Pembrolizumab for Advanced Cutaneous Sarcomas Not Including Angiosarcoma
Pembrolizumab for Advanced Cutaneous Sarcomas Not Including Angiosarcoma
Recruiting · NCT07007273 · Registry updated 2026-04-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Pembrolizumab for Advanced Cutaneous Sarcomas Not Including Angiosarcoma | skin sarcoma | Recruiting | Phase 2 | 2026-04-01 | NCT07007273 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| H. Lee Moffitt Cancer Center and Research Institute | 162 |
| Merck Sharp & Dohme LLC | 650 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| MD Anderson Cancer Center | Houston | United States | 589 |
| Moffitt Cancer Center | Tampa | United States | 523 |
| Ohio State University Comprehensive Cancer Center | Columbus | United States | 548 |